Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea · Delayed Price · Currency is KRW 2,480.00
0.00 (0.00%)
At close: Sep 11, 2026
Korea Arlico Pharm Market Cap
Korea Arlico Pharm has a market cap or net worth of 38.01 billion as of September 11, 2026. Its market cap has decreased by -43.38% in one year.
Market Cap
38.01B
Enterprise Value
58.19B
Revenue
195.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,480.00
ChartMarket Cap Chart
Since February 12, 2018, Korea Arlico Pharm's market cap has decreased from 207.83B to 38.01B, a decrease of -81.71%. That is a compound annual growth rate of -17.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 38.01B | -41.99% |
| Dec 30, 2025 | 65.52B | 23.73% |
| Dec 30, 2024 | 52.95B | -39.39% |
| Dec 28, 2023 | 87.36B | -12.98% |
| Dec 29, 2022 | 100.39B | -14.71% |
| Dec 30, 2021 | 117.71B | -17.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RP Bio | 51.82B |
| Jin Yang Pharmaceutical | 51.06B |
| Organoidsciences | 43.80B |
| Kyung Nam Pharm | 43.26B |
| GeneBioTech Co. ,Ltd | 41.55B |
| Eagle Veterinary Technology Co.,Ltd | 39.76B |
| Korean Drug | 36.99B |
| Pharmsville | 28.13B |